Quantitative computed tomography imaging biomarkers in the diagnosis and management of lung cancer

Tumor diameter has traditionally been used as a standard metric in terms of diagnosis and prognosis prediction of lung cancer. However, recent advances in imaging techniques and data analyses have enabled novel quantitative imaging biomarkers that can characterize disease status more comprehensively...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, Hyungjin (Author) , Park, Chang Min (Author) , Goo, Jin Mo (Author) , Wildberger, Joachim E. (Author) , Kauczor, Hans-Ulrich (Author)
Format: Article (Journal)
Language:English
Published: 2015
In: Investigative radiology
Year: 2015, Volume: 50, Issue: 9, Pages: 571-583
ISSN:1536-0210
DOI:10.1097/RLI.0000000000000152
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/RLI.0000000000000152
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/investigativeradiology/Fulltext/2015/09000/Quantitative_Computed_Tomography_Imaging.4.aspx
Get full text
Author Notes:Hyungjin Kim, Chang Min Park, Jin Mo Goo, Joachim E. Wildberger, and Hans-Ulrich Kauczor
Description
Summary:Tumor diameter has traditionally been used as a standard metric in terms of diagnosis and prognosis prediction of lung cancer. However, recent advances in imaging techniques and data analyses have enabled novel quantitative imaging biomarkers that can characterize disease status more comprehensively and/or predict tumor behavior more precisely. The most widely used imaging modality for lung tumor assessment is computed tomography. Therefore, we focused on computed tomography imaging biomarkers such as tumor volume and mass, ground-glass opacities, perfusion parameters, as well as texture features in this review. Herein, we first appraised the conventional 1- or 2-dimensional measurement with brief discussion on their limits and then introduced the potential imaging biomarkers with emphasis on the current understanding of their clinical usefulness with respect to the malignancy differentiation, treatment response monitoring, and patient outcome prediction.
Item Description:Gesehen am 01.07.2020
Physical Description:Online Resource
ISSN:1536-0210
DOI:10.1097/RLI.0000000000000152